Ar, LLC

Also on record

Records under this name other than the patents Ar, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 46 patents it holds.

Back to Ar, LLC

Patent	Title	Status	Expires	Confidence
US 7,569,612	Methods of Use of Fenofibric Acid now held by Rosemont Pharmaceuticals LLC In force (reinstated) Term ends Aug 20, 2027 · Medium confidence	In force (reinstated)	Term ends Aug 20, 2027	Medium confidence
US 7,741,373	Methods of Use of Fenofibric Acid now held by Rosemont Pharmaceuticals LLC In force Term ends Aug 20, 2027 · Medium confidence	In force	Term ends Aug 20, 2027	Medium confidence
US 7,741,374	Methods of Use of Fenofibric Acid now held by Rosemont Pharmaceuticals LLC In force Term ends Aug 20, 2027 · Medium confidence	In force	Term ends Aug 20, 2027	Medium confidence
US 7,915,247	Methods of Use of Fenofibric Acid now held by Rosemont Pharmaceuticals LLC In force Term ends Aug 20, 2027 · Medium confidence	In force	Term ends Aug 20, 2027	Medium confidence
US 7,964,647	Colchicine Compositions and Methods now held by Takeda Pharmaceutical Company Limited In force Term ends Oct 6, 2028 · Medium confidence	In force	Term ends Oct 6, 2028	Medium confidence
US 7,981,938	Colchicine Compositions and Methods now held by Takeda Pharmaceutical Company Limited In force Term ends Oct 6, 2028 · Medium confidence	In force	Term ends Oct 6, 2028	Medium confidence
US 7,619,004	Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics now held by Takeda Pharmaceuticals U.S.A., Inc. In force Term ends Dec 3, 2028 · High confidence	In force	Term ends Dec 3, 2028	High confidence
US 7,935,731	Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics now held by Takeda Pharmaceuticals U.S.A., Inc. In force Term ends Dec 3, 2028 · Medium confidence	In force	Term ends Dec 3, 2028	Medium confidence
US 8,093,296	Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics now held by Takeda Pharmaceuticals U.S.A., Inc. In force Ends no later than Dec 3, 2028 · Low confidence	In force	Ends no later than Dec 3, 2028	Low confidence
US 8,093,298	Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics now held by Takeda Pharmaceuticals U.S.A., Inc. In force Ends no later than Dec 3, 2028 · Low confidence	In force	Ends no later than Dec 3, 2028	Low confidence

10 of 142 records shown.

Pro members see all 142.

Pro members: see all 142 records